Guiling Li
Impact in
- Pharmaceutical Science top 5%
- Advancements in Transdermal Drug Delivery
- Advanced Drug Delivery Systems
- Biochemistry top 10%
- Eicosanoids and Hypertension Pharmacology
Papers in
-
- Liver Disease Diagnosis and Treatment 7
-
- Liver physiology and pathology 7
- Liver Diseases and Immunity 2
- Liver Disease and Transplantation 1
- Co-authors
- Xinru Li (3 shared papers)Yating Fan (2 shared papers)Mei Li (2 shared papers)Liu Liu (1 shared paper)Matthew L. Edin (1 shared paper)Darryl C. Zeldin (1 shared paper)Ding Ma (1 shared paper)Jianfeng Zhou (1 shared paper)
- Journals
- Pharmaceuticals (2 papers)ACS Nano (2 papers)Molecules (2 papers)Journal of Pharmacology and Experimental Therapeutics (1 paper)International Journal of Pharmaceutics (1 paper)
- Partner nations
- ChinaUnited States
In The Last Decade
Guiling Li
15 papers receiving 327 citations
Peers
Comparison fields: 5 of 87
- Pharmaceutical Science 68
- Biochemistry 74
- Pharmacology 58
- Hepatology 36
- Biomaterials 42
Countries citing papers authored by Guiling Li
This map shows the geographic impact of Guiling Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guiling Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guiling Li more than expected).
Fields of papers citing papers by Guiling Li
This network shows the impact of papers produced by Guiling Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guiling Li. The network helps show where Guiling Li may publish in the future.
Co-authors
The 25 scholars most cited alongside Guiling Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2009 | 88 | |
| 2 | 2012 | 41 | |
| 3 | 2014 | 32 | |
| 4 | 2012 | 31 | |
| 5 | 2016 | 29 | |
| 6 | 2023 | 20 | |
| 7 | 2019 | 16 | |
| 8 | 2018 | 14 | |
| 9 | 2021 | 13 | |
| 10 | 2017 | 12 | |
| 11 | 2021 | 11 | |
| 12 | 2017 | 11 | |
| 13 | 2025 | 6 | |
| 14 | 2022 | 5 | |
| 15 | 2022 | 4 | |
| 16 | 2025 | 0 |
About Guiling Li
Guiling Li is a scholar working on Epidemiology, Hepatology, Molecular Biology, Surgery and Pharmacology, having authored 16 papers that have together received 333 indexed citations. Recurring topics across this work include Liver physiology and pathology (7 papers), Liver Disease Diagnosis and Treatment (7 papers), Nanoparticle-Based Drug Delivery (2 papers), Liver Diseases and Immunity (2 papers), Drug-Induced Hepatotoxicity and Protection (2 papers), Advancements in Transdermal Drug Delivery (2 papers), RNA Interference and Gene Delivery (2 papers) and Liver Disease and Transplantation (1 paper). The work is most often cited by research in Pharmaceutical Science (68 citations), Biochemistry (74 citations), Pharmacology (58 citations), Hepatology (36 citations) and Biomaterials (42 citations). Guiling Li has collaborated with scholars based in China and United States. Frequent co-authors include Xinru Li, Yating Fan, Mei Li, Liu Liu, Matthew L. Edin, Darryl C. Zeldin, Ding Ma, Jianfeng Zhou, Jun Wu and Xucheng Hou. Their work appears in journals such as Pharmaceuticals, ACS Nano, Molecules, Journal of Pharmacology and Experimental Therapeutics and International Journal of Pharmaceutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.